Legal Representation
Attorney
Paul C. Llewellyn
USPTO Deadlines
Application History
21 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Nov 7, 2022 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Nov 7, 2022 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Apr 5, 2022 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Feb 8, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Feb 8, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jan 19, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jan 4, 2022 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Jan 4, 2022 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jan 4, 2022 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jan 4, 2022 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jan 4, 2022 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Dec 2, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Dec 2, 2021 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Dec 2, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jun 2, 2021 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jun 2, 2021 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jun 2, 2021 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| May 29, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 17, 2021 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Feb 16, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Dec 12, 2020 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 016
Printed materials, namely, brochures, leaflets, reports, and newsletters on the topics of medicine, medical research, scientific research, research and development of pharmaceuticals, biological preparations and gene therapy products, rare diseases, neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, genetic therapy research, and diagnosis and treatment of genetic disorders
Class 042
Medical research; medical and scientific research services all in the field of rare diseases; medical and scientific research services all in the field of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, and genetic diseases and disorders; medical and scientific research services all in the field of gene therapy, gene editing, genome editing, viruses, viral vectors, and viral constructs; providing information relating to medical research, scientific research, research and development of pharmaceuticals, biological preparations and gene therapy products, and medical research in the field of genetic therapy; providing information via a website in the field of medical research, scientific research, research and development of pharmaceuticals, biological preparations and gene therapy products, and medical research in the field of genetic therapy
Class 044
Medical information services, namely, providing information relating to medicine, rare diseases, neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and diagnosis and treatment of genetic disorders; Providing medical information via a website in the field of medicine, diseases, neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and diagnosis and treatment of genetic disorders; Providing medical information to doctors and patients regarding rare diseases, medicines, health conditions and treatment options
Additional Information
Design Mark
The mark consists of a dot and two dashes with the word "TRIGENESIS" underneath.
Classification
International Classes
016
042
044